PCS-2023 > 3 > 3E > 3E0 > 3E0C |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0C | Introduction, Eye | |
3E0C3 | Percutaneous | |
3E0C30 | Antineoplastic | |
3E0C304 | Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach | |
3E0C305 | Introduction of Other Antineoplastic into Eye, Percutaneous Approach | |
3E0C30M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach | |
3E0C32 | Anti-infective | |
3E0C328 | Introduction of Oxazolidinones into Eye, Percutaneous Approach | |
3E0C329 | Introduction of Other Anti-infective into Eye, Percutaneous Approach | |
3E0C33 | Anti-inflammatory | |
3E0C33Z | Introduction of Anti-inflammatory into Eye, Percutaneous Approach | |
3E0C3B | Anesthetic Agent | |
3E0C3BZ | Introduction of Anesthetic Agent into Eye, Percutaneous Approach | |
3E0C3H | Radioactive Substance | |
3E0C3HZ | Introduction of Radioactive Substance into Eye, Percutaneous Approach | |
3E0C3K | Other Diagnostic Substance | |
3E0C3KZ | Introduction of Other Diagnostic Substance into Eye, Percutaneous Approach | |
3E0C3M | Pigment | |
3E0C3MZ | Introduction of Pigment into Eye, Percutaneous Approach | |
3E0C3N | Analgesics, Hypnotics, Sedatives | |
3E0C3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach | |
3E0C3T | Destructive Agent | |
3E0C3TZ | Introduction of Destructive Agent into Eye, Percutaneous Approach | |
3E0C3G | Other Therapeutic Substance | |
3E0C3GC | Introduction of Other Therapeutic Substance into Eye, Percutaneous Approach | |
3E0C3S | Gas | |
3E0C3SF | Introduction of Other Gas into Eye, Percutaneous Approach | |
3E0C7 | Via Natural or Artificial Opening | |
3E0C70 | Antineoplastic | |
3E0C704 | Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening | |
3E0C705 | Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening | |
3E0C70M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening | |
3E0C72 | Anti-infective | |
3E0C728 | Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening | |
3E0C729 | Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening | |
3E0C73 | Anti-inflammatory | |
3E0C73Z | Introduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening | |
3E0C7B | Anesthetic Agent | |
3E0C7BZ | Introduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening | |
3E0C7H | Radioactive Substance | |
3E0C7HZ | Introduction of Radioactive Substance into Eye, Via Natural or Artificial Opening | |
3E0C7K | Other Diagnostic Substance | |
3E0C7KZ | Introduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening | |
3E0C7M | Pigment | |
3E0C7MZ | Introduction of Pigment into Eye, Via Natural or Artificial Opening | |
3E0C7N | Analgesics, Hypnotics, Sedatives | |
3E0C7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening | |
3E0C7T | Destructive Agent | |
3E0C7TZ | Introduction of Destructive Agent into Eye, Via Natural or Artificial Opening | |
3E0C7G | Other Therapeutic Substance | |
3E0C7GC | Introduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening | |
3E0C7S | Gas | |
3E0C7SF | Introduction of Other Gas into Eye, Via Natural or Artificial Opening | |
3E0CX | External | |
3E0CX0 | Antineoplastic | |
3E0CX04 | Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach | |
3E0CX05 | Introduction of Other Antineoplastic into Eye, External Approach | |
3E0CX0M | Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach | |
3E0CX2 | Anti-infective | |
3E0CX28 | Introduction of Oxazolidinones into Eye, External Approach | |
3E0CX29 | Introduction of Other Anti-infective into Eye, External Approach | |
3E0CX3 | Anti-inflammatory | |
3E0CX3Z | Introduction of Anti-inflammatory into Eye, External Approach | |
3E0CXB | Anesthetic Agent | |
3E0CXBZ | Introduction of Anesthetic Agent into Eye, External Approach | |
3E0CXH | Radioactive Substance | |
3E0CXHZ | Introduction of Radioactive Substance into Eye, External Approach | |
3E0CXK | Other Diagnostic Substance | |
3E0CXKZ | Introduction of Other Diagnostic Substance into Eye, External Approach | |
3E0CXM | Pigment | |
3E0CXMZ | Introduction of Pigment into Eye, External Approach | |
3E0CXN | Analgesics, Hypnotics, Sedatives | |
3E0CXNZ | Introduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach | |
3E0CXT | Destructive Agent | |
3E0CXTZ | Introduction of Destructive Agent into Eye, External Approach | |
3E0CXG | Other Therapeutic Substance | |
3E0CXGC | Introduction of Other Therapeutic Substance into Eye, External Approach | |
3E0CXS | Gas | |
3E0CXSF | Introduction of Other Gas into Eye, External Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |